Balasa Dinverno & Foltz’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $265K | Buy |
3,277
+644
| +24% | +$57.9K | 0.02% | 286 |
|
|
2022
Q2 | $236K | Sell |
2,633
-186
| -7% | -$18.8K | 0.01% | 302 |
|
|
2022
Q1 | $313K | Sell |
2,819
-247
| -8% | -$26.1K | 0.02% | 260 |
|
|
2021
Q4 | $317K | Sell |
3,066
-780
| -20% | -$90.3K | 0.02% | 264 |
|
|
2021
Q3 | $482K | Buy |
3,846
+455
| +13% | +$58.9K | 0.03% | 196 |
|
|
2021
Q2 | $421K | Buy |
3,391
+384
| +13% | +$48.2K | 0.03% | 208 |
|
|
2021
Q1 | $355K | Sell |
3,007
-238
| -7% | -$27.9K | 0.03% | 217 |
|
|
2020
Q4 | $380K | Buy |
3,245
+208
| +7% | +$22.9K | 0.03% | 196 |
|
|
2020
Q3 | $316K | Sell |
3,037
-128
| -4% | -$12.9K | 0.03% | 200 |
|
|
2020
Q2 | $290K | Sell |
3,165
-742
| -19% | -$71.2K | 0.03% | 177 |
|
|
2020
Q1 | $352K | Sell |
3,907
-3,367
| -46% | -$358K | 0.04% | 166 |
|
|
2019
Q4 | $825K | Buy |
7,274
+2,234
| +44% | +$245K | 0.09% | 111 |
|
|
2019
Q3 | $547K | Buy |
5,040
+1,459
| +41% | +$152K | 0.06% | 141 |
|
|
2019
Q2 | $349K | Sell |
3,581
-554
| -13% | -$50.6K | 0.04% | 176 |
|
|
2019
Q1 | $377K | Sell |
4,135
-1,058
| -20% | -$94.7K | 0.05% | 161 |
|
|
2018
Q4 | $472K | Buy |
5,193
+344
| +7% | +$32.1K | 0.06% | 131 |
|
|
2018
Q3 | $477K | Buy |
4,849
+1,439
| +42% | +$133K | 0.05% | 143 |
|
|
2018
Q2 | $292K | Buy |
3,410
+463
| +16% | +$38.7K | 0.04% | 176 |
|
|
2018
Q1 | $236K | Sell |
2,947
-673
| -19% | -$55.5K | 0.04% | 193 |
|
|
2017
Q4 | $292K | Sell |
3,620
-325
| -8% | -$26K | 0.04% | 172 |
|
|
2017
Q3 | $307K | Buy |
3,945
+2
| +0.1% | +$166 | 0.05% | 164 |
|
|
2017
Q2 | $350K | Buy |
3,943
+814
| +26% | +$68.6K | 0.06% | 152 |
|
|
2017
Q1 | $252K | Sell |
3,129
-606
| -16% | -$47.3K | 0.04% | 174 |
|
|
2016
Q4 | $266K | Buy |
3,735
+637
| +21% | +$50K | 0.05% | 155 |
|
|
2016
Q3 | $268K | Buy |
3,098
+311
| +11% | +$27.1K | 0.05% | 150 |
|
|
2016
Q2 | $242K | Sell |
2,787
-132
| -5% | -$10.7K | 0.04% | 154 |
|
|
2016
Q1 | $219K | Buy |
+2,919
| New | +$220K | 0.04% | 161 |
|
|
2015
Q1 | – | Sell |
-4,649
| Closed | -$336K | – | 211 |
|
|
2014
Q4 | $336K | Sell |
4,649
-44
| -0.9% | -$3.06K | 0.05% | 133 |
|
|
2014
Q3 | $291K | Sell |
4,693
-141
| -3% | -$8.96K | 0.04% | 133 |
|
|
2014
Q2 | $308K | Buy |
4,834
+218
| +5% | +$13.2K | 0.04% | 124 |
|
|
2014
Q1 | $284K | Buy |
4,616
+18
| +0.4% | +$1.05K | 0.03% | 129 |
|
|
2013
Q4 | $264K | Buy |
4,598
+74
| +2% | +$4.2K | 0.04% | 124 |
|
|
2013
Q3 | $241K | Sell |
4,524
-617
| -12% | -$33.2K | 0.04% | 122 |
|
|
2013
Q2 | $265K | Buy |
+5,141
| New | +$254K | 0.05% | 106 |
|
Other funds holding MDT
Balasa Dinverno & Foltz's MDT Position: Q3 2022 in Review
Balasa Dinverno & Foltz increased its Medtronic (MDT) stake by 24% in Q3 2022, buying an estimated $57.9K and bringing the position to 3,277 shares worth $265K. The position accounts for 0.02% of the portfolio, ranked #286.
Balasa Dinverno & Foltz first reported a position in MDT in Q2 2013 and has held it in 34 quarters since. The position peaked at $825K in Q4 2019. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Balasa Dinverno & Foltz held 3,277 shares of Medtronic worth $265K as of Q3 2022.
- Balasa Dinverno & Foltz bought 644 Medtronic shares in Q3 2022, an estimated $57.9K.
- Medtronic made up 0.02% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #286 holding.
- Balasa Dinverno & Foltz first reported a position in Medtronic in Q2 2013 and has held it in 34 quarters since.
- Balasa Dinverno & Foltz's Medtronic position peaked at $825K in Q4 2019.
- 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.